These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8884530)

  • 1. FK506 and cyclosporin A inhibit growth factor-stimulated human keratinocyte proliferation by blocking cells in the G0/G1 phases of the cell cycle.
    Karashima T; Hachisuka H; Sasai Y
    J Dermatol Sci; 1996 Sep; 12(3):246-54. PubMed ID: 8884530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of cyclosporin A and FK506 on proliferation and IL-8 production of cultured human keratinocytes.
    Kaplan A; Matsue H; Shibaki A; Kawashima T; Kobayashi H; Ohkawara A
    J Dermatol Sci; 1995 Sep; 10(2):130-8. PubMed ID: 8534611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporine in psoriasis treatment. Inhibition of keratinocyte cell-cycle progression in G1 independent of effects on transforming growth factor alpha/epidermal growth factor receptor pathways.
    Khandke L; Krane JF; Ashinoff R; Staiano-Coico L; Granelli-Piperno A; Luster AD; Carter DM; Krueger JG; Gottlieb AB
    Arch Dermatol; 1991 Aug; 127(8):1172-9. PubMed ID: 1677800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FK506 independently upregulates transforming growth factor beta and downregulates inducible nitric oxide synthase in cultured human keratinocytes: possible mechanisms of how tacrolimus ointment interacts with atopic skin.
    Lan CC; Kao YH; Huang SM; Yu HS; Chen GS
    Br J Dermatol; 2004 Sep; 151(3):679-84. PubMed ID: 15377358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapamycin (sirolimus) inhibits proliferating cell nuclear antigen expression and blocks cell cycle in the G1 phase in human keratinocyte stem cells.
    Javier AF; Bata-Csorgo Z; Ellis CN; Kang S; Voorhees JJ; Cooper KD
    J Clin Invest; 1997 May; 99(9):2094-9. PubMed ID: 9151781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporin A, FK506 and dithranol after tyrosine-specific protein phosphorylation in HaCaT keratinocytes.
    Ockenfels HM; Nussbaum G; Schultewolter T; Burger PM; Goos M
    Arch Dermatol Res; 1995; 287(3-4):304-9. PubMed ID: 7541191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FK506 and cyclosporin A inhibit stem cell factor-dependent cell proliferation/survival, while inducing upregulation of c-kit expression in cells of the mast cell line MC/9.
    Ito F; Toyota N; Sakai H; Takahashi H; Iizuka H
    Arch Dermatol Res; 1999 May; 291(5):275-83. PubMed ID: 10367710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of FK506 and cyclosporin A on proliferation, histamine release and phenotype of murine mast cells.
    Toyota N; Hashimoto Y; Matsuo S; Kitamura Y; Iizuka H
    Arch Dermatol Res; 1996 Jul; 288(8):474-80. PubMed ID: 8844128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of growth factors on the proliferation of human keratinocytes and fibroblasts in vitro.
    Kim DS; Korting HC; Schäfer-Korting M
    Pharmazie; 1998 Jan; 53(1):51-7. PubMed ID: 9476258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effect of rapamycin and cyclosporin A in proliferation in a murine T cell line expressing either intermediate or high affinity receptor for IL-2.
    Rebollo A; Mérida I; Gómez J; Pitton C; Silva A; Martínez C; García A
    Cytokine; 1995 Apr; 7(3):277-86. PubMed ID: 7543780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporin A, but not FK506, increases arachidonic acid release and inhibits proliferation of pituitary corticotrope tumor cells.
    Pompeo A; Baldassare M; Luini A; Buccione R
    Life Sci; 1999; 64(10):837-46. PubMed ID: 10096434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of the immunosuppressants cyclosporin A, FK506 and KM2210 on cytokine gene expression.
    Han CW; Imamura M; Hashino S; Zhu X; Tanaka J; Imai K; Matsudaira T; Asano S
    Bone Marrow Transplant; 1995 May; 15(5):733-9. PubMed ID: 7545487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different effects of cyclosporine a and FK506 on potassium transport systems in MDCK cells.
    Aker S; Heering P; Kinne-Saffran E; Deppe C; Grabensee B; Kinne RK
    Exp Nephrol; 2001; 9(5):332-40. PubMed ID: 11549851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localization of calcineurin/NFAT in human skin and psoriasis and inhibition of calcineurin/NFAT activation in human keratinocytes by cyclosporin A.
    Al-Daraji WI; Grant KR; Ryan K; Saxton A; Reynolds NJ
    J Invest Dermatol; 2002 May; 118(5):779-88. PubMed ID: 11982754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin modulates the growth and adherence and augments the growth-inhibitory action of TNF-alpha on cultured human keratinocytes.
    Harvima IT; Lappalainen K; Hirvonen MR; Mättö M; Kivinen PK; Hyttinen M; Pelkonen J; Naukkarinen A
    J Cell Biochem; 2004 May; 92(2):372-86. PubMed ID: 15108362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor beta 1 regulation of c-myc expression, pRB phosphorylation, and cell cycle progression in keratinocytes.
    Münger K; Pietenpol JA; Pittelkow MR; Holt JT; Moses HL
    Cell Growth Differ; 1992 May; 3(5):291-8. PubMed ID: 1633111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential inhibition of cutaneous T-cell-mediated reactions and epidermal cell proliferation by cyclosporin A, FK-506, and rapamycin.
    Duncan JI
    J Invest Dermatol; 1994 Jan; 102(1):84-8. PubMed ID: 7507155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of rapamycin, cyclosporine A, and FK506 on human coronary artery smooth muscle cell proliferation and signalling.
    Hafizi S; Mordi VN; Andersson KM; Chester AH; Yacoub MH
    Vascul Pharmacol; 2004; 41(4-5):167-76. PubMed ID: 15607500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immunosuppressant rapamycin, alone or with transforming growth factor-beta, enhances osteoclast differentiation of RAW264.7 monocyte-macrophage cells in the presence of RANK-ligand.
    Shui C; Riggs BL; Khosla S
    Calcif Tissue Int; 2002 Nov; 71(5):437-46. PubMed ID: 12202955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth inhibitory effects of FK506 and cyclosporin A independent of inhibition of calcineurin.
    Richter A; Davies DE; Alexander P
    Biochem Pharmacol; 1995 Jan; 49(3):367-73. PubMed ID: 7531976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.